Global Hepatitis B and C Diagnostics Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

October 2018 | 149 pages | ID: GDE89A0DE5DEN
GlobalInfoResearch

Abstracts

Hepatitis B diagnostic tests include HBV serologic tests, molecular deoxyribonucleic acid (DNA) tests, histology tests, and laboratory tests. HBV serologic tests involve the measurement of antigens and antibodies. Hepatitis C diagnostic tests include anti-HCV serologic test, HCV recombinant immunoblot assay (RIBA) antibody test, and HCV molecular ribonucleic acid (RNA) testing. Anti-HCV is the serologic test used for screening.

Scope of the Report:

This report studies the Hepatitis B and C Diagnostics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Hepatitis B and C Diagnostics market by product type and applications/end industries.

The increasing demand for molecular diagnostic of HBV (hepatitis B virus) and HCV (hepatitis C virus) infections is one of the primary drivers for the growth of this market. Molecular diagnosis simplifies sample preparation for high-volume testing and includes identification and profiling of causative agents of infection and the quantification of pathogens to monitor durability of therapy; thus, resulting in sales of around 60% of the overall molecular diagnosis market. Additionally, new companies are also focusing on the development of new products, which, in turn, is expected to change market dynamics for the diagnosis of HBV and HCV infections. For instance, Cepheid recently announced a quantitative test that offers on-demand molecular testing for confirmation of infection and monitoring of HCV and has obtained CE-IVD (in vitro diagnostics) status under the European Directive on in-vitro diagnostic medical devices, making it one of the leading platforms for molecular diagnosis.

Increasing incidence of HBV and HCV infections in the Americas will contribute to the growth of the diagnostic market. The Americas will dominate the market, accounting for half of the total market share by 2023. The recent increase in blood transfusion will result in the adoption of third-generation hepatitis C diagnostic tests like HCV enzyme immunoassay that contribute to the growth of the market in this region. Also, the implementation of biomarker-based POC (point-of-care) tests initiated by the government and non-profit organizations, is also expected to drive the market growth as the products are highly accessible and easy to use.

The global Hepatitis B and C Diagnostics market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Hepatitis B and C Diagnostics.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

• Roche Diagnostics
• Abbott
• Siemens
• Qiagen
• Alere
• bioMérieux
• Cepheid
• Chembio Diagnostics
• DiaSorin
• Enzo Life Sciences
• Hologic
• MedMira
• OraSure Technologies
• Quest Diagnostics
• Quidel Corp
• Randox Laboratories

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Market Segment by Type, covers

• Hepatitis B
• Hepatitis C

Market Segment by Applications, can be divided into

• Immunodiagnostics
• Nucleic Acid Test (NAT)
  
  

Contents

1 HEPATITIS B AND C DIAGNOSTICS MARKET OVERVIEW

1.1 Product Overview and Scope of Hepatitis B and C Diagnostics
1.2 Classification of Hepatitis B and C Diagnostics by Types
  1.2.1 Global Hepatitis B and C Diagnostics Revenue Comparison by Types (2017-2023)
  1.2.2 Global Hepatitis B and C Diagnostics Revenue Market Share by Types in 2017
  1.2.3 Hepatitis B
  1.2.4 Hepatitis C
1.3 Global Hepatitis B and C Diagnostics Market by Application
  1.3.1 Global Hepatitis B and C Diagnostics Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Immunodiagnostics
  1.3.3 Nucleic Acid Test (NAT)
1.4 Global Hepatitis B and C Diagnostics Market by Regions
  1.4.1 Global Hepatitis B and C Diagnostics Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Hepatitis B and C Diagnostics Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Hepatitis B and C Diagnostics Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Hepatitis B and C Diagnostics Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Hepatitis B and C Diagnostics Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Hepatitis B and C Diagnostics Status and Prospect (2013-2023)
1.5 Global Market Size of Hepatitis B and C Diagnostics (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Roche Diagnostics
  2.1.1 Business Overview
  2.1.2 Hepatitis B and C Diagnostics Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Roche Diagnostics Hepatitis B and C Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.2 Abbott
  2.2.1 Business Overview
  2.2.2 Hepatitis B and C Diagnostics Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Abbott Hepatitis B and C Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.3 Siemens
  2.3.1 Business Overview
  2.3.2 Hepatitis B and C Diagnostics Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Siemens Hepatitis B and C Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.4 Qiagen
  2.4.1 Business Overview
  2.4.2 Hepatitis B and C Diagnostics Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Qiagen Hepatitis B and C Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.5 Alere
  2.5.1 Business Overview
  2.5.2 Hepatitis B and C Diagnostics Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Alere Hepatitis B and C Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.6 bioMérieux
  2.6.1 Business Overview
  2.6.2 Hepatitis B and C Diagnostics Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 bioMérieux Hepatitis B and C Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.7 Cepheid
  2.7.1 Business Overview
  2.7.2 Hepatitis B and C Diagnostics Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Cepheid Hepatitis B and C Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.8 Chembio Diagnostics
  2.8.1 Business Overview
  2.8.2 Hepatitis B and C Diagnostics Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 Chembio Diagnostics Hepatitis B and C Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.9 DiaSorin
  2.9.1 Business Overview
  2.9.2 Hepatitis B and C Diagnostics Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 DiaSorin Hepatitis B and C Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.10 Enzo Life Sciences
  2.10.1 Business Overview
  2.10.2 Hepatitis B and C Diagnostics Type and Applications
    2.10.2.1 Product A
    2.10.2.2 Product B
  2.10.3 Enzo Life Sciences Hepatitis B and C Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.11 Hologic
  2.11.1 Business Overview
  2.11.2 Hepatitis B and C Diagnostics Type and Applications
    2.11.2.1 Product A
    2.11.2.2 Product B
  2.11.3 Hologic Hepatitis B and C Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.12 MedMira
  2.12.1 Business Overview
  2.12.2 Hepatitis B and C Diagnostics Type and Applications
    2.12.2.1 Product A
    2.12.2.2 Product B
  2.12.3 MedMira Hepatitis B and C Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.13 OraSure Technologies
  2.13.1 Business Overview
  2.13.2 Hepatitis B and C Diagnostics Type and Applications
    2.13.2.1 Product A
    2.13.2.2 Product B
  2.13.3 OraSure Technologies Hepatitis B and C Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.14 Quest Diagnostics
  2.14.1 Business Overview
  2.14.2 Hepatitis B and C Diagnostics Type and Applications
    2.14.2.1 Product A
    2.14.2.2 Product B
  2.14.3 Quest Diagnostics Hepatitis B and C Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.15 Quidel Corp
  2.15.1 Business Overview
  2.15.2 Hepatitis B and C Diagnostics Type and Applications
    2.15.2.1 Product A
    2.15.2.2 Product B
  2.15.3 Quidel Corp Hepatitis B and C Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.16 Randox Laboratories
  2.16.1 Business Overview
  2.16.2 Hepatitis B and C Diagnostics Type and Applications
    2.16.2.1 Product A
    2.16.2.2 Product B
  2.16.3 Randox Laboratories Hepatitis B and C Diagnostics Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL HEPATITIS B AND C DIAGNOSTICS MARKET COMPETITION, BY PLAYERS

3.1 Global Hepatitis B and C Diagnostics Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Hepatitis B and C Diagnostics Players Market Share
  3.2.2 Top 10 Hepatitis B and C Diagnostics Players Market Share
3.3 Market Competition Trend

4 GLOBAL HEPATITIS B AND C DIAGNOSTICS MARKET SIZE BY REGIONS

4.1 Global Hepatitis B and C Diagnostics Revenue and Market Share by Regions
4.2 North America Hepatitis B and C Diagnostics Revenue and Growth Rate (2013-2018)
4.3 Europe Hepatitis B and C Diagnostics Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Hepatitis B and C Diagnostics Revenue and Growth Rate (2013-2018)
4.5 South America Hepatitis B and C Diagnostics Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Hepatitis B and C Diagnostics Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA HEPATITIS B AND C DIAGNOSTICS REVENUE BY COUNTRIES

5.1 North America Hepatitis B and C Diagnostics Revenue by Countries (2013-2018)
5.2 USA Hepatitis B and C Diagnostics Revenue and Growth Rate (2013-2018)
5.3 Canada Hepatitis B and C Diagnostics Revenue and Growth Rate (2013-2018)
5.4 Mexico Hepatitis B and C Diagnostics Revenue and Growth Rate (2013-2018)

6 EUROPE HEPATITIS B AND C DIAGNOSTICS REVENUE BY COUNTRIES

6.1 Europe Hepatitis B and C Diagnostics Revenue by Countries (2013-2018)
6.2 Germany Hepatitis B and C Diagnostics Revenue and Growth Rate (2013-2018)
6.3 UK Hepatitis B and C Diagnostics Revenue and Growth Rate (2013-2018)
6.4 France Hepatitis B and C Diagnostics Revenue and Growth Rate (2013-2018)
6.5 Russia Hepatitis B and C Diagnostics Revenue and Growth Rate (2013-2018)
6.6 Italy Hepatitis B and C Diagnostics Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC HEPATITIS B AND C DIAGNOSTICS REVENUE BY COUNTRIES

7.1 Asia-Pacific Hepatitis B and C Diagnostics Revenue by Countries (2013-2018)
7.2 China Hepatitis B and C Diagnostics Revenue and Growth Rate (2013-2018)
7.3 Japan Hepatitis B and C Diagnostics Revenue and Growth Rate (2013-2018)
7.4 Korea Hepatitis B and C Diagnostics Revenue and Growth Rate (2013-2018)
7.5 India Hepatitis B and C Diagnostics Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Hepatitis B and C Diagnostics Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA HEPATITIS B AND C DIAGNOSTICS REVENUE BY COUNTRIES

8.1 South America Hepatitis B and C Diagnostics Revenue by Countries (2013-2018)
8.2 Brazil Hepatitis B and C Diagnostics Revenue and Growth Rate (2013-2018)
8.3 Argentina Hepatitis B and C Diagnostics Revenue and Growth Rate (2013-2018)
8.4 Colombia Hepatitis B and C Diagnostics Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE HEPATITIS B AND C DIAGNOSTICS BY COUNTRIES

9.1 Middle East and Africa Hepatitis B and C Diagnostics Revenue by Countries (2013-2018)
9.2 Saudi Arabia Hepatitis B and C Diagnostics Revenue and Growth Rate (2013-2018)
9.3 UAE Hepatitis B and C Diagnostics Revenue and Growth Rate (2013-2018)
9.4 Egypt Hepatitis B and C Diagnostics Revenue and Growth Rate (2013-2018)
9.5 Nigeria Hepatitis B and C Diagnostics Revenue and Growth Rate (2013-2018)
9.6 South Africa Hepatitis B and C Diagnostics Revenue and Growth Rate (2013-2018)

10 GLOBAL HEPATITIS B AND C DIAGNOSTICS MARKET SEGMENT BY TYPE

10.1 Global Hepatitis B and C Diagnostics Revenue and Market Share by Type (2013-2018)
10.2 Global Hepatitis B and C Diagnostics Market Forecast by Type (2018-2023)
10.3 Hepatitis B Revenue Growth Rate (2013-2023)
10.4 Hepatitis C Revenue Growth Rate (2013-2023)

11 GLOBAL HEPATITIS B AND C DIAGNOSTICS MARKET SEGMENT BY APPLICATION

11.1 Global Hepatitis B and C Diagnostics Revenue Market Share by Application (2013-2018)
11.2 Hepatitis B and C Diagnostics Market Forecast by Application (2018-2023)
11.3 Immunodiagnostics Revenue Growth (2013-2018)
11.4 Nucleic Acid Test (NAT) Revenue Growth (2013-2018)

12 GLOBAL HEPATITIS B AND C DIAGNOSTICS MARKET SIZE FORECAST (2018-2023)

12.1 Global Hepatitis B and C Diagnostics Market Size Forecast (2018-2023)
12.2 Global Hepatitis B and C Diagnostics Market Forecast by Regions (2018-2023)
12.3 North America Hepatitis B and C Diagnostics Revenue Market Forecast (2018-2023)
12.4 Europe Hepatitis B and C Diagnostics Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Hepatitis B and C Diagnostics Revenue Market Forecast (2018-2023)
12.6 South America Hepatitis B and C Diagnostics Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Hepatitis B and C Diagnostics Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Hepatitis B and C Diagnostics Picture
Table Product Specifications of Hepatitis B and C Diagnostics
Table Global Hepatitis B and C Diagnostics and Revenue (Million USD) Market Split by Product Type
Figure Global Hepatitis B and C Diagnostics Revenue Market Share by Types in 2017
Figure Hepatitis B Picture
Figure Hepatitis C Picture
Table Global Hepatitis B and C Diagnostics Revenue (Million USD) by Application (2013-2023)
Figure Hepatitis B and C Diagnostics Revenue Market Share by Applications in 2017
Figure Immunodiagnostics Picture
Figure Nucleic Acid Test (NAT) Picture
Table Global Market Hepatitis B and C Diagnostics Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Hepatitis B and C Diagnostics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Hepatitis B and C Diagnostics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Hepatitis B and C Diagnostics Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Hepatitis B and C Diagnostics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Hepatitis B and C Diagnostics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Hepatitis B and C Diagnostics Revenue (Million USD) and Growth Rate (2013-2023)
Table Roche Diagnostics Basic Information, Manufacturing Base and Competitors
Table Roche Diagnostics Hepatitis B and C Diagnostics Type and Applications
Table Roche Diagnostics Hepatitis B and C Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
Table Abbott Basic Information, Manufacturing Base and Competitors
Table Abbott Hepatitis B and C Diagnostics Type and Applications
Table Abbott Hepatitis B and C Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
Table Siemens Basic Information, Manufacturing Base and Competitors
Table Siemens Hepatitis B and C Diagnostics Type and Applications
Table Siemens Hepatitis B and C Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
Table Qiagen Basic Information, Manufacturing Base and Competitors
Table Qiagen Hepatitis B and C Diagnostics Type and Applications
Table Qiagen Hepatitis B and C Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
Table Alere Basic Information, Manufacturing Base and Competitors
Table Alere Hepatitis B and C Diagnostics Type and Applications
Table Alere Hepatitis B and C Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
Table bioMérieux Basic Information, Manufacturing Base and Competitors
Table bioMérieux Hepatitis B and C Diagnostics Type and Applications
Table bioMérieux Hepatitis B and C Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
Table Cepheid Basic Information, Manufacturing Base and Competitors
Table Cepheid Hepatitis B and C Diagnostics Type and Applications
Table Cepheid Hepatitis B and C Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
Table Chembio Diagnostics Basic Information, Manufacturing Base and Competitors
Table Chembio Diagnostics Hepatitis B and C Diagnostics Type and Applications
Table Chembio Diagnostics Hepatitis B and C Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
Table DiaSorin Basic Information, Manufacturing Base and Competitors
Table DiaSorin Hepatitis B and C Diagnostics Type and Applications
Table DiaSorin Hepatitis B and C Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
Table Enzo Life Sciences Basic Information, Manufacturing Base and Competitors
Table Enzo Life Sciences Hepatitis B and C Diagnostics Type and Applications
Table Enzo Life Sciences Hepatitis B and C Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
Table Hologic Basic Information, Manufacturing Base and Competitors
Table Hologic Hepatitis B and C Diagnostics Type and Applications
Table Hologic Hepatitis B and C Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
Table MedMira Basic Information, Manufacturing Base and Competitors
Table MedMira Hepatitis B and C Diagnostics Type and Applications
Table MedMira Hepatitis B and C Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
Table OraSure Technologies Basic Information, Manufacturing Base and Competitors
Table OraSure Technologies Hepatitis B and C Diagnostics Type and Applications
Table OraSure Technologies Hepatitis B and C Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
Table Quest Diagnostics Basic Information, Manufacturing Base and Competitors
Table Quest Diagnostics Hepatitis B and C Diagnostics Type and Applications
Table Quest Diagnostics Hepatitis B and C Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
Table Quidel Corp Basic Information, Manufacturing Base and Competitors
Table Quidel Corp Hepatitis B and C Diagnostics Type and Applications
Table Quidel Corp Hepatitis B and C Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
Table Randox Laboratories Basic Information, Manufacturing Base and Competitors
Table Randox Laboratories Hepatitis B and C Diagnostics Type and Applications
Table Randox Laboratories Hepatitis B and C Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
Table Global Hepatitis B and C Diagnostics Revenue (Million USD) by Players (2013-2018)
Table Global Hepatitis B and C Diagnostics Revenue Share by Players (2013-2018)
Figure Global Hepatitis B and C Diagnostics Revenue Share by Players in 2016
Figure Global Hepatitis B and C Diagnostics Revenue Share by Players in 2017
Figure Global Top 5 Players Hepatitis B and C Diagnostics Revenue Market Share in 2017
Figure Global Top 10 Players Hepatitis B and C Diagnostics Revenue Market Share in 2017
Figure Global Hepatitis B and C Diagnostics Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Hepatitis B and C Diagnostics Revenue (Million USD) by Regions (2013-2018)
Table Global Hepatitis B and C Diagnostics Revenue Market Share by Regions (2013-2018)
Figure Global Hepatitis B and C Diagnostics Revenue Market Share by Regions (2013-2018)
Figure Global Hepatitis B and C Diagnostics Revenue Market Share by Regions in 2017
Figure North America Hepatitis B and C Diagnostics Revenue and Growth Rate (2013-2018)
Figure Europe Hepatitis B and C Diagnostics Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Hepatitis B and C Diagnostics Revenue and Growth Rate (2013-2018)
Figure South America Hepatitis B and C Diagnostics Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Hepatitis B and C Diagnostics Revenue and Growth Rate (2013-2018)
Table North America Hepatitis B and C Diagnostics Revenue by Countries (2013-2018)
Table North America Hepatitis B and C Diagnostics Revenue Market Share by Countries (2013-2018)
Figure North America Hepatitis B and C Diagnostics Revenue Market Share by Countries (2013-2018)
Figure North America Hepatitis B and C Diagnostics Revenue Market Share by Countries in 2017
Figure USA Hepatitis B and C Diagnostics Revenue and Growth Rate (2013-2018)
Figure Canada Hepatitis B and C Diagnostics Revenue and Growth Rate (2013-2018)
Figure Mexico Hepatitis B and C Diagnostics Revenue and Growth Rate (2013-2018)
Table Europe Hepatitis B and C Diagnostics Revenue (Million USD) by Countries (2013-2018)
Figure Europe Hepatitis B and C Diagnostics Revenue Market Share by Countries (2013-2018)
Figure Europe Hepatitis B and C Diagnostics Revenue Market Share by Countries in 2017
Figure Germany Hepatitis B and C Diagnostics Revenue and Growth Rate (2013-2018)
Figure UK Hepatitis B and C Diagnostics Revenue and Growth Rate (2013-2018)
Figure France Hepatitis B and C Diagnostics Revenue and Growth Rate (2013-2018)
Figure Russia Hepatitis B and C Diagnostics Revenue and Growth Rate (2013-2018)
Figure Italy Hepatitis B and C Diagnostics Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Hepatitis B and C Diagnostics Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Hepatitis B and C Diagnostics Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Hepatitis B and C Diagnostics Revenue Market Share by Countries in 2017
Figure China Hepatitis B and C Diagnostics Revenue and Growth Rate (2013-2018)
Figure Japan Hepatitis B and C Diagnostics Revenue and Growth Rate (2013-2018)
Figure Korea Hepatitis B and C Diagnostics Revenue and Growth Rate (2013-2018)
Figure India Hepatitis B and C Diagnostics Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Hepatitis B and C Diagnostics Revenue and Growth Rate (2013-2018)
Table South America Hepatitis B and C Diagnostics Revenue by Countries (2013-2018)
Table South America Hepatitis B and C Diagnostics Revenue Market Share by Countries (2013-2018)
Figure South America Hepatitis B and C Diagnostics Revenue Market Share by Countries (2013-2018)
Figure South America Hepatitis B and C Diagnostics Revenue Market Share by Countries in 2017
Figure Brazil Hepatitis B and C Diagnostics Revenue and Growth Rate (2013-2018)
Figure Argentina Hepatitis B and C Diagnostics Revenue and Growth Rate (2013-2018)
Figure Colombia Hepatitis B and C Diagnostics Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Hepatitis B and C Diagnostics Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Hepatitis B and C Diagnostics Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Hepatitis B and C Diagnostics Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Hepatitis B and C Diagnostics Revenue Market Share by Countries in 2017
Figure Saudi Arabia Hepatitis B and C Diagnostics Revenue and Growth Rate (2013-2018)
Figure UAE Hepatitis B and C Diagnostics Revenue and Growth Rate (2013-2018)
Figure Egypt Hepatitis B and C Diagnostics Revenue and Growth Rate (2013-2018)
Figure Nigeria Hepatitis B and C Diagnostics Revenue and Growth Rate (2013-2018)
Figure South Africa Hepatitis B and C Diagnostics Revenue and Growth Rate (2013-2018)
Table Global Hepatitis B and C Diagnostics Revenue (Million USD) by Type (2013-2018)
Table Global Hepatitis B and C Diagnostics Revenue Share by Type (2013-2018)
Figure Global Hepatitis B and C Diagnostics Revenue Share by Type (2013-2018)
Figure Global Hepatitis B and C Diagnostics Revenue Share by Type in 2017
Table Global Hepatitis B and C Diagnostics Revenue Forecast by Type (2018-2023)
Figure Global Hepatitis B and C Diagnostics Market Share Forecast by Type (2018-2023)
Figure Global Hepatitis B Revenue Growth Rate (2013-2018)
Figure Global Hepatitis C Revenue Growth Rate (2013-2018)
Table Global Hepatitis B and C Diagnostics Revenue by Application (2013-2018)
Table Global Hepatitis B and C Diagnostics Revenue Share by Application (2013-2018)
Figure Global Hepatitis B and C Diagnostics Revenue Share by Application (2013-2018)
Figure Global Hepatitis B and C Diagnostics Revenue Share by Application in 2017
Table Global Hepatitis B and C Diagnostics Revenue Forecast by Application (2018-2023)
Figure Global Hepatitis B and C Diagnostics Market Share Forecast by Application (2018-2023)
Figure Global Immunodiagnostics Revenue Growth Rate (2013-2018)
Figure Global Nucleic Acid Test (NAT) Revenue Growth Rate (2013-2018)
Figure Global Hepatitis B and C Diagnostics Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Hepatitis B and C Diagnostics Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Hepatitis B and C Diagnostics Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Hepatitis B and C Diagnostics Revenue Market Forecast (2018-2023)
Figure Europe Hepatitis B and C Diagnostics Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Hepatitis B and C Diagnostics Revenue Market Forecast (2018-2023)
Figure South America Hepatitis B and C Diagnostics Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Hepatitis B and C Diagnostics Revenue Market Forecast (2018-2023)